GSK buys full rights to make COVID, influenza vaccines from CureVac
Wednesday, July 3rd 2024, 6:25:52 am
article
The deal is the result of restructuring a collaboration, which began in 2020 to develop mRNA-based vaccines for infectious diseases, into a new licensing agreement, GSK added. As a result of the collaboration, the two companies have vaccine candidates for seasonal influenza and COVID-19 in phase II clinical development and avian influenza in phase I clinical development.
Breaking
At least 19 people were injured when a stampede broke out at Atlantic Beach, South Carolina beach early Sunday morning, according to officials....
Alexandria Ocasio-Cortez sparked backlash from southern conservatives after she delivered a speech in Montgomery, Alabama behind bulletproof glass demanding that progressives "pull up to the South."...
GOP lawmakers dismiss concerns over Trump targeting Republican incumbents after Rep. Thomas Massie's primary loss, stressing party unity ahead of midterms....
